These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 16034482)
61. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story. François M; Richette P; Corvol MT Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482 [TBL] [Abstract][Full Text] [Related]
62. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma. Park SJ; Lee YC J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989 [TBL] [Abstract][Full Text] [Related]
63. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Belvisi MG; Hele DJ; Birrell MA Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290 [TBL] [Abstract][Full Text] [Related]
64. Peroxisome proliferator-activated receptor gamma (PPAR gamma) and sepsis. von Knethen A; Soller M; Brüne B Arch Immunol Ther Exp (Warsz); 2007; 55(1):19-25. PubMed ID: 17277894 [TBL] [Abstract][Full Text] [Related]
65. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700 [TBL] [Abstract][Full Text] [Related]
66. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Touyz RM; Schiffrin EL Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410 [TBL] [Abstract][Full Text] [Related]
67. PPAR and Pain. Maeda T; Kishioka S Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969 [TBL] [Abstract][Full Text] [Related]
68. Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma. Varga T; Nagy L Eur J Clin Invest; 2008 Oct; 38(10):695-707. PubMed ID: 18837794 [TBL] [Abstract][Full Text] [Related]
69. The many faces of PPARgamma: anti-inflammatory by any means? Szanto A; Nagy L Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294 [TBL] [Abstract][Full Text] [Related]
70. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Martin H Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816 [TBL] [Abstract][Full Text] [Related]
71. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents. Kaundal RK; Sharma SS Drug News Perspect; 2010 May; 23(4):241-56. PubMed ID: 20520853 [TBL] [Abstract][Full Text] [Related]
72. [Anti-atherosclerotic effects by PPARgamma and its ligands through the activation of reverse cholesterol transport system]. Wakino S; Itoh H Nihon Rinsho; 2010 Feb; 68(2):217-23. PubMed ID: 20158087 [TBL] [Abstract][Full Text] [Related]
73. Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response. Ren L; Konger RL Mol Carcinog; 2019 Sep; 58(9):1589-1601. PubMed ID: 31111568 [TBL] [Abstract][Full Text] [Related]
74. Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease. Magri CJ; Gatt N; Xuereb RG; Fava S Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1279-94. PubMed ID: 21985541 [TBL] [Abstract][Full Text] [Related]
75. [PPARgamma as a new therapeutic target in inflammatory diseases]. Naito Y; Yoshikawa T Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107 [TBL] [Abstract][Full Text] [Related]